Home/CVE/Traefik is an HTTP reverse proxy and load balancer. From 3.7.0-ea.1 until 3.7.5, there is a medium severity vulnerabilit
CVE

CVE-2026-54762

Traefik is an HTTP reverse proxy and load balancer. From 3.7.0-ea.1 until 3.7.5, there is a medium severity vulnerabilit

Traefik is an HTTP reverse proxy and load balancer. From 3.7.0-ea.1 until 3.7.5, there is a medium severity vulnerability in Traefik's Kubernetes Ingress NGINX provider that causes affected routes to fail open. When an Ingress explicitly enables BasicAuth or DigestAuth through the supported nginx.ingress.kubernetes.io/auth-type and auth-secret annotations, but the referenced auth Secret cannot be resolved or parsed, Traefik logs the resolution error, skips installing the authentication middleware, and still emits a router to the backend service.

A route that operators intended to protect is therefore published to the data plane without its authentication control, allowing unauthenticated access to the backend. The trigger is an invalid or unresolved auth dependency, a missing, malformed, unreadable, or policy-denied Secret, rather than an intentionally unprotected route. This vulnerability is fixed in 3.7.5.

Monitor
  • ⚠ NVD has not scored this CVE yet - manual triage required (common for recent CVEs)
Look this up elsewhere - one-click external pivots
How to read a CVE - triage first, then detect and patch
This page is every public fact about CVE-2026-54762, cross-linked. Its job is to answer one question fast - does this need my attention now? - and then hand you the two things you do about it. Here is how an analyst reads it.
Triage: should I act now? Four signals, and they are not interchangeable:
CVSSseverity - how bad it is IF exploited, 0-10. A high CVSS alone is not urgency; a flaw can be a perfect 10 and never actually be attacked. EPSSprobability - a model’s estimate of the chance it is exploited in the next 30 days, 0-1. This is the “will it actually happen” signal. CISA KEVconfirmed - it is being exploited in the wild right now. The strongest signal on the page; KEV beats any score. Weaponisedavailability - public exploits / PoCs, and especially Metasploit modules rated Excellent / Great. Reliable, packaged exploit code means low-skill attackers can use it today.
How they combine: KEV, or a dependable Metasploit module, means patch now regardless of CVSS. High CVSS + low EPSS + no exploit is real but not an emergency - schedule it. Low CVSS but KEV-listed still gets patched now. The verdict above already weighed these for you; this is how it got there.
Then what - two workflows:
Detectwhen you cannot patch today, follow this CVE to the ATT&CK techniques it enables, then Build a SIEM detection (the green button) - author a rule, test it in Atomic, deploy it. That buys visibility while the patch waits. PatchAffected products / packages tell you if you are exposed; Fixed versions by distribution and Vendor advisories give the exact version that closes it.
Reading order for the panels below: verdict + badges, then Public exploits / Metasploit (is it weaponised), then ATT&CK techniques + Sigma / IDS rules (can I detect it), then Affected products / packages + Fixed versions (am I exposed, what patches it), then Threat actors / IOCs (who uses it), then Scoring & timeline / references (the evidence).

ATT&CK techniques

1

Techniques this CVE enables. Pills with a solid outline are high confidence - named directly in ATT&CK or Nuclei, or human-curated by CTID; the rest are inferred from the weakness type using MITRE's CVE Mapping Methodology and the CWE → CAPEC chain. Broad, generic-weakness guesses are filtered out. A small marks a technique that N independent sources agree on.

▤ Build a SIEM detection for these techniques

Affected Packages

1
Language-ecosystem packages (from OSV) tied to this CVE, with the version that fixes it - the dependency-level detail NVD doesn’t carry.
Go github.com/traefik/traefik/v3 MODERATE fixed in 3.7.5
🔗

References & Sources

2
Source URLs (vendor pages, mailing lists, write-ups). Exploit/PoC links are in their own section above to avoid duplication.